Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positron Emission Tomography Computed Tomography | 4 | 2024 | 58 | 2.170 |
Why?
|
| Sarcoidosis | 2 | 2023 | 33 | 1.520 |
Why?
|
| Lymphadenopathy | 2 | 2021 | 22 | 1.360 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2021 | 101 | 0.830 |
Why?
|
| Cerebral Infarction | 1 | 2024 | 84 | 0.830 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 192 | 0.800 |
Why?
|
| Melanoma | 2 | 2023 | 331 | 0.660 |
Why?
|
| Pancreas | 3 | 2018 | 154 | 0.660 |
Why?
|
| Vaccination | 1 | 2021 | 371 | 0.570 |
Why?
|
| Biliary Tract | 1 | 2018 | 9 | 0.560 |
Why?
|
| Multimodal Imaging | 1 | 2018 | 71 | 0.530 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 118 | 0.510 |
Why?
|
| Neoplasms | 1 | 2021 | 1392 | 0.330 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 1669 | 0.320 |
Why?
|
| Lung Neoplasms | 3 | 2022 | 695 | 0.300 |
Why?
|
| Humans | 21 | 2024 | 64279 | 0.250 |
Why?
|
| Diagnosis, Differential | 5 | 2021 | 984 | 0.250 |
Why?
|
| Immunoconjugates | 2 | 2021 | 93 | 0.230 |
Why?
|
| Ultrasonography | 2 | 2018 | 486 | 0.220 |
Why?
|
| Radioactive Tracers | 1 | 2024 | 3 | 0.220 |
Why?
|
| Biological Transport | 1 | 2024 | 291 | 0.200 |
Why?
|
| Pancreatitis | 2 | 2014 | 98 | 0.200 |
Why?
|
| Dissent and Disputes | 1 | 2022 | 9 | 0.190 |
Why?
|
| Bone Marrow | 1 | 2023 | 175 | 0.180 |
Why?
|
| Transanal Endoscopic Surgery | 1 | 2022 | 29 | 0.180 |
Why?
|
| Sarcopenia | 1 | 2022 | 28 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 108 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 166 | 0.170 |
Why?
|
| Catheter Ablation | 1 | 2022 | 155 | 0.170 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 68 | 0.160 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 421 | 0.160 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2020 | 6 | 0.160 |
Why?
|
| Ampulla of Vater | 1 | 2020 | 12 | 0.160 |
Why?
|
| Neoplasms, Second Primary | 1 | 2020 | 50 | 0.160 |
Why?
|
| Rectal Neoplasms | 1 | 2022 | 128 | 0.160 |
Why?
|
| Patient Safety | 1 | 2022 | 243 | 0.160 |
Why?
|
| Simulation Training | 1 | 2019 | 66 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 2218 | 0.140 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2018 | 47 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2021 | 223 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2022 | 501 | 0.130 |
Why?
|
| Lymphoma, T-Cell | 1 | 2017 | 24 | 0.130 |
Why?
|
| Pelvic Pain | 1 | 2016 | 19 | 0.130 |
Why?
|
| Abdomen, Acute | 1 | 2016 | 23 | 0.130 |
Why?
|
| Disease Progression | 1 | 2021 | 1176 | 0.130 |
Why?
|
| Atrial Flutter | 1 | 2016 | 27 | 0.120 |
Why?
|
| Air Pollutants, Occupational | 1 | 2016 | 74 | 0.120 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2016 | 57 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 350 | 0.120 |
Why?
|
| Testicular Neoplasms | 1 | 2016 | 35 | 0.120 |
Why?
|
| Male | 9 | 2024 | 30323 | 0.110 |
Why?
|
| Radiology | 1 | 2019 | 257 | 0.110 |
Why?
|
| Jejunal Diseases | 1 | 2014 | 7 | 0.110 |
Why?
|
| Duodenal Diseases | 1 | 2014 | 15 | 0.110 |
Why?
|
| Choristoma | 1 | 2014 | 23 | 0.110 |
Why?
|
| Communication | 1 | 2019 | 587 | 0.110 |
Why?
|
| Colon, Descending | 1 | 2014 | 1 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 259 | 0.110 |
Why?
|
| Colonic Diseases | 1 | 2014 | 35 | 0.100 |
Why?
|
| Occupational Exposure | 1 | 2016 | 315 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 383 | 0.090 |
Why?
|
| Aged | 2 | 2024 | 14664 | 0.080 |
Why?
|
| Acute Disease | 3 | 2016 | 672 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2022 | 5697 | 0.070 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2007 | 23 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2007 | 37 | 0.070 |
Why?
|
| Stroke | 1 | 2016 | 1196 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2007 | 53 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 220 | 0.060 |
Why?
|
| Female | 6 | 2022 | 33382 | 0.050 |
Why?
|
| Microwaves | 1 | 2022 | 14 | 0.050 |
Why?
|
| Rectum | 1 | 2022 | 93 | 0.040 |
Why?
|
| Radiologists | 1 | 2022 | 93 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2021 | 75 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 358 | 0.040 |
Why?
|
| SEER Program | 1 | 2020 | 75 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 210 | 0.040 |
Why?
|
| Pneumonectomy | 1 | 2020 | 116 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 529 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 735 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2019 | 219 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 859 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 457 | 0.030 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2017 | 3 | 0.030 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2017 | 4 | 0.030 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2017 | 7 | 0.030 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 9 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 321 | 0.030 |
Why?
|
| Enoxaparin | 1 | 2016 | 17 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 49 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 69 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 2016 | 12 | 0.030 |
Why?
|
| Pelvis | 1 | 2016 | 61 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 870 | 0.030 |
Why?
|
| Abdomen | 1 | 2016 | 94 | 0.030 |
Why?
|
| Aphasia | 1 | 2016 | 46 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 676 | 0.030 |
Why?
|
| Electric Countershock | 1 | 2016 | 103 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 607 | 0.030 |
Why?
|
| Middle Aged | 3 | 2020 | 17923 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2022 | 1301 | 0.030 |
Why?
|
| Rupture | 1 | 2014 | 24 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2019 | 730 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2482 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2014 | 193 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2016 | 511 | 0.020 |
Why?
|
| Contrast Media | 1 | 2014 | 429 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2019 | 808 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 6742 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 2370 | 0.020 |
Why?
|
| United States | 1 | 2022 | 7923 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1561 | 0.020 |
Why?
|
| Copper Radioisotopes | 1 | 2007 | 1 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 167 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2007 | 385 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 1494 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 17133 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 11003 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 20962 | 0.000 |
Why?
|